Jenner Investigators, including Professor Lucy Dorrell have published a study in Frontiers in Immunology showing that a two-in-one vaccine regimen employing serologically distinct adenovirus vectors elicited strong immune responses to both pathogens without adverse effects
A Novel Vaccine Strategy Employing Serologically Different Adenoviral Vectors for the Prevention of HIV-1 and HCV Coinfection
11 April 2019
Nearly 3 million people are co-infected with hepatitis C and HIV. Effective preventive strategies targeting both viruses are needed.